What is the lead time for delivery?

Off-season lead time is within 15 workdays, and peak season lead time is one month.

Which ports are nearest for export?

The nearest ports are Shanghai, Qingdao, and Tianjin.

Methyl 5-Bromovalerate CAS 5454-83-1 Fine Chemical

Name: Methyl 5-Bromovalerate CAS 5454-83-1 Fine Chemical
Brand: Puyer Biopharma Ltd.
SKU: 2156988285

Jiangsu, ChinaPuyer Biopharma Ltd.

US$1.00-10.00

1 Piece

Sample price:US$50.00/piece.Request sample

Product profile

Customization

Available

CAS No.

5454-83-1

Formula

N/a

Model NO.

Fine Chemical

EINECS

N/a

Type

Synthesis Material Intermediates

Appearance

Liquid

Quality

Industrial

Colour

Colorless

Transport Package

Drum

Specification

99%

Trademark

PUYER

Origin

China

Production Capacity

100000kg/Month

Key features

High Purity Fine Chemical: Features high purity levels and specific molecular structures for complex synthesis.

Customized Batch Production: Production in customized batches to meet rigorous specifications.

Wide Industry Application: Utilized in pharmaceuticals, agrochemicals, electronics, automotive, cosmetics, and construction.

Strict Quality Control: Complex production process with strict quality control and adherence to standards.

Colorless Liquid Form: Appears as a colorless liquid suitable for industrial synthesis intermediates.

Global Market Reach: Exports to North America, South America, Europe, Asia, Africa, and Oceania.

Flexible Payment Options: Accepts LC, T/T, D/P, PayPal, Western Union, and cash payments.

Fast Lead Time: Off-season lead time within 15 workdays; peak season within one month.

Company profile

Puyer Biopharma Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading Company, OtherExport Year: 2016-08-01Nearest Port: shanghai, qingdao, tianjinAverage Response Time: ≤9.40hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW

AI-Powered supplier vetting

SummaryPuyer Biopharma Ltd. is identified as a China-based limited company operating from Nantong, Jiangsu, with manufacturer/factory and trading-company classifications. Its stated scope covers APIs, intermediates, fine chemicals, nutraceuticals, crop science, animal health, and related services. Evidence indicates ISO 9001 certification, 21–30 years of combined R&D engineer experience, 6–10 quality-control staff, 10 production lines, batch production of more than 300 products, and multiple production or testing locations. The supplier exports independently, began exporting in 2016, and reports broad international market coverage. However, the provided information does not establish after-sales service processes, financial credibility, customization execution, or named customer cases. Indexes 8 and 9 identify a different entity, Tieling Municipal People’s Government, and are excluded from supplier conclusions.

Supplier typeThe supplier is described as a factory, manufacturer, and trading company. Puyer Biopharma Ltd. is a China-based limited company located in Nantong, Jiangsu, and its stated business covers production, R&D, and sales of pharmaceutical, chemical, nutrition, agricultural, and related products.

CertificationsThe supplier explicitly reports ISO 9001 certification for its management system. This provides direct evidence of a recognized quality-management certification, although no additional certifications are stated.

R&D capabilityPuyer is described as a high-tech enterprise founded by doctors and specializing in R&D, with 21–30 years of R&D engineer experience. It reports laboratories, testing centers, production bases, and investment in R&D testing and production equipment, directly supporting substantial innovation and technical-development capability.

Production capacityThe supplier reports 10 production lines, batch production of more than 300 products, multiple production bases, and stated annual capacities for salicylic acid, potassium humate, amino acid powder, dicalcium phosphate, and choline chloride. These figures provide explicit evidence of broad and sizable production capability.